Metabolic Syndrome in Women with and Without Stress Urinary Incontinence

Overview

Journal Int Urogynecol J

Publisher Springer

Specialties Gynecology & Obstetrics
Urology

Date 2019 Feb 6

PMID 30721325

Citations 16

Authors

Rejane Lis Menegaz Stroher

Marair Gracio Ferreira Sartori

Claudia Cristina Takano

Maita Poli de Araujo

Manoel Joao Batista Castelo Girao

Affiliations

Soon will be listed here.

Abstract

Introduction: Metabolic syndrome (MS) is a disease of multifactorial etiology characterized by increased waist circumference, elevated triglyceride levels, decreased HDL cholesterol levels, high blood pressure and hyperglycemia. The objective of this study was to compare the frequency of MS in patients with and without stress urinary incontinence (SUI).

Methods: The components of MS were evaluated in 85 women with SUI seen at the Urogynecology and Vaginal Surgery Sector of the Gynecology Department of Universidade Federal de São Paulo (UNIFESP-EPM) and in 108 women without SUI seen at the General Gynecology Clinic of the Gynecology Department of UNIFESP-EPM.

Results: The MS diagnosis was more prevalent in patients with SUI, with the frequency according to the International Diabetes Federation criteria being 69.4% in the case group with SUI and 38% in the control group, whereas according to the National Cholesterol Education Program Adult Treatment Panel III recommendations, MS was frequent in 64.7% of the cases and 25% of the controls. Each MS component was evaluated, and the body mass index, weight and waist circumference were significantly higher in the case group (with SUI) compared with the control group (p < 0.001). The women in the case group showed an average HDL cholesterol value statistically lower and triglyceride and glycemia values statistically higher than the women in the control group (p < 0.001 and p = 0.005).

Conclusion: MS frequency was higher in patients with SUI, which shows a possible association between these two conditions.

Citing Articles

Cardiometabolic Index and Stress Urinary Incontinence in US Women: The Mediating Role of the Triglyceride Glucose Index.

Yang Q, Cao Y Int Urogynecol J. 2025; .

PMID: 39812814 DOI: 10.1007/s00192-025-06044-x.

Association between lipid accumulation products and stress urinary incontinence: a cross-sectional study from NHANES 2005 to 2018.

Li J, Wang D, Tian H, Yang J, Xia H, Guo W Lipids Health Dis. 2024; 23(1):358.

PMID: 39497148 PMC: 11533302. DOI: 10.1186/s12944-024-02350-3.

Cardiovascular health assessed by the new life's essential 8 and the prevalence of urinary incontinence in adults.

Xiao Y, Tang Y, Wang J, Yin S, Bai Y, Cui J BMC Public Health. 2024; 24(1):2136.

PMID: 39107742 PMC: 11304804. DOI: 10.1186/s12889-024-19604-5.

Association of plasma high-density lipoprotein cholesterol level with risk of stress urinary incontinence in women: a retrospective study.

Xu W, Zheng B, Su L, Xiang Y Lipids Health Dis. 2024; 23(1):171.

PMID: 38849942 PMC: 11157702. DOI: 10.1186/s12944-024-02137-6.

The association between non-alcoholic fatty liver disease and urinary incontinence among adult females in the United States.

Li X, Zhou W, Hu G BMC Public Health. 2024; 24(1):1373.

PMID: 38778285 PMC: 11110403. DOI: 10.1186/s12889-024-18578-8.

References

Tai H, Chung S, Ho C, Tai T, Yang W, Tseng C . Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes. J Clin Endocrinol Metab. 2010; 95(3):1143-50. DOI: 10.1210/jc.2009-1492. View

Walker G, Gunasekera P . Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors. Int Urogynecol J. 2010; 22(2):127-35. DOI: 10.1007/s00192-010-1215-0. View

Haylen B, Ridder D, Freeman R, Swift S, Berghmans B, Lee J . An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2009; 29(1):4-20. DOI: 10.1002/nau.20798. View

. [VI Brazilian Guidelines on Hypertension]. Arq Bras Cardiol. 2010; 95(1 Suppl):1-51. View

Avery K, Donovan J, Peters T, Shaw C, Gotoh M, Abrams P . ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004; 23(4):322-30. DOI: 10.1002/nau.20041. View

Dwyer P, Lee E, Hay D . Obesity and urinary incontinence in women. Br J Obstet Gynaecol. 1988; 95(1):91-6. DOI: 10.1111/j.1471-0528.1988.tb06486.x. View

Hannestad Y, Rortveit G, Sandvik H, Hunskaar S . A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trøndelag. J Clin Epidemiol. 2000; 53(11):1150-7. DOI: 10.1016/s0895-4356(00)00232-8. View

Kim Y, Kim J, Kim S, Choi Y, Jeon M . Association between metabolic syndrome and pelvic floor dysfunction in middle-aged to older Korean women. Am J Obstet Gynecol. 2011; 205(1):71.e1-8. DOI: 10.1016/j.ajog.2011.02.047. View

Danforth K, Townsend M, Lifford K, Curhan G, Resnick N, Grodstein F . Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol. 2006; 194(2):339-45. PMC: 1363686. DOI: 10.1016/j.ajog.2005.07.051. View

10.

Lifford K, Curhan G, Hu F, Barbieri R, Grodstein F . Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Soc. 2005; 53(11):1851-7. DOI: 10.1111/j.1532-5415.2005.53565.x. View

11.

Hunskaar S . A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn. 2008; 27(8):749-57. DOI: 10.1002/nau.20635. View

12.

Otunctemur A, Dursun M, Ozbek E, Sahin S, Besiroglu H, Koklu I . Impact of metabolic syndrome on stress urinary incontinence in pre- and postmenopausal women. Int Urol Nephrol. 2014; 46(8):1501-5. DOI: 10.1007/s11255-014-0680-7. View

13.

. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

14.

Lawrence J, Lukacz E, Liu I, Nager C, Luber K . Pelvic floor disorders, diabetes, and obesity in women: findings from the Kaiser Permanente Continence Associated Risk Epidemiology Study. Diabetes Care. 2007; 30(10):2536-41. DOI: 10.2337/dc07-0262. View

15.

Hunskaar S, Arnold E, Burgio K, Diokno A, Herzog A, Mallett V . Epidemiology and natural history of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2000; 11(5):301-19. DOI: 10.1007/s001920070021. View

16.

Subak L, Whitcomb E, Shen H, Saxton J, Vittinghoff E, Brown J . Weight loss: a novel and effective treatment for urinary incontinence. J Urol. 2005; 174(1):190-5. PMC: 1557356. DOI: 10.1097/01.ju.0000162056.30326.83. View

17.

Maserejian N, Giovannucci E, McVary K, McGrother C, McKinlay J . Dietary macronutrient and energy intake and urinary incontinence in women. Am J Epidemiol. 2010; 171(10):1116-25. PMC: 2877472. DOI: 10.1093/aje/kwq065. View

18.

Reynolds W, Dmochowski R, Penson D . Epidemiology of stress urinary incontinence in women. Curr Urol Rep. 2011; 12(5):370-6. DOI: 10.1007/s11934-011-0206-0. View

19.

Tamanini J, Almeida F, Girotti M, Riccetto C, Palma P, Rios L . The Portuguese validation of the International Consultation on Incontinence Questionnaire-Vaginal Symptoms (ICIQ-VS) for Brazilian women with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2008; 19(10):1385-91. DOI: 10.1007/s00192-008-0641-8. View

20.

Bump R, Mattiasson A, Bo K, Brubaker L, DeLancey J, Klarskov P . The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996; 175(1):10-7. DOI: 10.1016/s0002-9378(96)70243-0. View